Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy.

Kanai, M; Matsumoto, S; Nishimura, T; Matsumura, Y; Hatano, E; Mori, A; Masui, T; Kawaguchi, Y; Nakamura, E; Tada, S; Kitano, T; Ishiguro, H; Yanagihara, K; Chiba, T

Kanai, M; Matsumoto, S; Nishimura, T; Matsumura, Y; Hatano, E; Mori, A; Masui, T; Kawaguchi, Y; Nakamura, E; Tada, S; Kitano, T; Ishiguro, H; Yanagihara, K; Chiba, T.

Ann Oncol ; 21(1): 189-90, 2010 Jan.

Article in En | MEDLINE | ID: mdl-19889615

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Antineoplastic Agents/adverse effects; Deoxycytidine/analogs & derivatives; Dexamethasone/therapeutic use; Exanthema/prevention & control; Premedication/methods; Aged; Deoxycytidine/adverse effects; Exanthema/chemically induced; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms/drug therapy; Secondary Prevention; Gemcitabine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Premedication / Dexamethasone / Deoxycytidine / Exanthema / Anti-Inflammatory Agents / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google